TURNER, WILLIAM W., JR.,LI, LEPING,HAYDAR, SIMON NICOLAS,BURES, MARK G.,RAI, ROOPA,FRANCIS, SAMSON,ARNOLD, LEE DANIEL
申请号：
CA3055194
公开号：
CA3055194A1
申请日:
2018.03.01
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present disclosure provides, in part, cyclic sulfamide compounds, and pharmaceutical compositions thereof, useful as modulators of Hepatitis B (HBV) core protein, and methods of treating Hepatitis B (HBV) infection.
